| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3330706
Max Phase: Preclinical
Molecular Formula: C11H17N2NaO7
Molecular Weight: 290.27
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)[O-])=C[C@@H]1N.[Na+]
Standard InChI: InChI=1S/C11H18N2O7.Na/c1-4(15)13-8-5(12)2-7(11(18)19)20-10(8)9(17)6(16)3-14;/h2,5-6,8-10,14,16-17H,3,12H2,1H3,(H,13,15)(H,18,19);/q;+1/p-1/t5-,6+,8+,9+,10+;/m0./s1
Standard InChI Key: CMVZCTCOKNPPRW-VCFRRRQNSA-M
Associated Targets(non-human)
LLC-MK2 227 Activities
Neuraminidase 2284 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 290.27 | Molecular Weight (Monoisotopic): 290.1114 | AlogP: -3.10 | #Rotatable Bonds: 5 |
| Polar Surface Area: 162.34 | Molecular Species: ACID | HBA: 7 | HBD: 6 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 3.08 | CX Basic pKa: 8.44 | CX LogP: -6.06 | CX LogD: -6.09 |
| Aromatic Rings: 0 | Heavy Atoms: 20 | QED Weighted: 0.31 | Np Likeness Score: 1.32 |
References
| 1. El-Deeb IM, Guillon P, Winger M, Eveno T, Haselhorst T, Dyason JC, von Itzstein M.. (2014) Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery., 57 (18): [PMID:25198831] [10.1021/jm500759v] |
Source
Source(1):